Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Satvat Ali J.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-07-03
Purchase
2019-07-08
9:32 pm
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
882,353 $29.9 $26,382,796 24,575,501
(Indirect)
View
2019-05-24
Purchase
2019-05-29
7:17 pm
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
1,103,848 $25.93 $28,622,779 23,693,148
(Indirect)
View
2018-12-31
Purchase
2019-02-14
6:24 pm
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
2,974,645 $14.87 $44,227,840 22,589,300
(Indirect)
View
2018-06-22
Purchase
2018-06-22
6:56 pm
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
1,000,000 $17 $17,000,000 22,523,684
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-22
Option Award
2022-06-24
4:34 pm
N/A
2032-06-22
BridgeBio Pharma Inc. BBIO Satvat Ali J.
Director
104,921 $0 104,921
(Direct)
View
2021-06-17
Option Award
2021-06-22
8:00 pm
N/A
2031-06-16
BridgeBio Pharma Inc. BBIO Satvat Ali J.
Director
38,895 $0 38,895
(Direct)
View
2021-04-22
Ownership
2021-04-22
7:12 pm
N/A
N/A
IMPEL NEUROPHARMA INC IMPL Satvat Ali J.
Director
0 $0 0
(Direct)
View
2021-01-26
Option Award
2021-01-28
8:40 pm
N/A
2030-05-27
BridgeBio Pharma Inc. BBIO Satvat Ali J.
Director
159,404 $0 159,404
(Direct)
View
2021-01-26
Disposition
2021-01-28
7:08 pm
N/A
2030-05-27
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
86,112 $0 0
(Direct)
View
2020-06-02
Option Award
2020-06-04
7:17 pm
N/A
2030-06-01
BridgeBio Pharma Inc. BBIO Satvat Ali J.
Director
10% Owner
112,422 $0 112,422
(Direct)
View
2020-05-27
Option Award
2020-05-29
4:05 pm
N/A
2030-05-27
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
21,528 $0 21,528
(Direct)
View
2020-01-10
Option Award
2020-01-14
5:55 pm
N/A
2030-01-10
Coherus BioSciences Inc. CHRS Satvat Ali J.
Director
20,000 $0 20,000
(Direct)
View
2019-12-12
Option Award
2019-12-16
8:56 pm
N/A
2029-12-11
BridgeBio Pharma Inc. BBIO Satvat Ali J.
Director
10% Owner
82,878 $0 82,878
(Direct)
View
2019-06-12
Option Award
2019-06-13
9:25 pm
N/A
2029-06-11
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
21,528 $0 21,528
(Direct)
View
2019-01-11
Option Award
2019-01-30
4:11 pm
N/A
2029-01-11
Coherus BioSciences Inc. CHRS Satvat Ali J.
Director
20,000 $0 20,000
(Direct)
View
2018-07-01
Option Award
2018-07-03
7:02 pm
N/A
2028-06-30
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
43,056 $0 43,056
(Direct)
View
2018-06-22
Conversion
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
34,567,569 $0 22,523,684
(Indirect)
View
2018-06-22
Tax Withholding
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
211,762 $17 22,523,684
(Indirect)
View
2018-06-22
Exercise
2018-06-22
6:56 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
664,524 $0 22,523,684
(Indirect)
View
2018-06-19
Ownership
2018-06-19
9:40 pm
N/A
N/A
Eidos Therapeutics Inc. EIDX Satvat Ali J.
Director
10% Owner
0 $0 18,761,294
(Indirect)
View
2018-02-01
Option Award
2018-02-05
4:07 pm
N/A
2028-02-01
Coherus BioSciences Inc. CHRS Satvat Ali J.
Director
20,000 $0 20,000
(Direct)
View